FDA Agrees To Waive User Fees For Reviews Of Lab-Developed Tests
This article was originally published in The Gray Sheet
Executive Summary
Although FDA is still developing its lab-developed test regulatory framework, it has agreed not to collect user fees to support its planned review of the tests.